Chimeric Therapeutics Limited
CHMMF
$0.001
-$0.029-96.67%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 30.51% | 54.46% | 29.54% | 25.66% | -2.49% |
| Total Receivables | -81.34% | -77.91% | -98.70% | -98.73% | 79.76% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -- | -- | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -89.73% | -87.84% | -75.00% | -75.73% | 1,924.59% |
| Total Current Assets | -54.12% | -45.70% | -65.46% | -66.49% | 57.56% |
|
|
|||||
| Total Current Assets | -54.12% | -45.70% | -65.46% | -66.49% | 57.56% |
| Net Property, Plant & Equipment | -- | -- | -86.49% | -89.47% | -87.65% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -16.25% | -0.88% | -7.23% | -10.01% | -6.90% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | -36.47% | -24.81% | -31.57% | -33.62% | 18.86% |
|
|
|||||
| Total Accounts Payable | 11.64% | 32.13% | -56.67% | -57.97% | 2,161.84% |
| Total Accrued Expenses | -35.82% | -24.04% | -13.85% | -16.43% | -42.03% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -24.98% | -11.21% | 4.23% | 1.11% | 13.51% |
| Total Other Current Liabilities | -24.98% | -11.21% | 4.23% | 1.11% | 13.51% |
| Total Current Liabilities | -8.91% | 7.80% | -31.11% | -33.17% | 59.50% |
|
|
|||||
| Total Current Liabilities | -8.91% | 7.80% | -31.11% | -33.17% | 59.50% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -13.42% | 2.47% | 34.14% | 30.13% | 1,590.21% |
| Total Liabilities | -9.84% | 6.71% | -23.21% | -25.51% | 95.94% |
|
|
|||||
| Common Stock & APIC | 3.82% | 22.87% | 18.06% | 14.53% | 13.38% |
| Retained Earnings | -18.92% | -40.74% | -17.51% | -14.00% | -24.73% |
| Treasury Stock & Other | -10.51% | 5.91% | -35.00% | -36.95% | 25.00% |
| Total Common Equity | -61.10% | -53.96% | -56.26% | -57.57% | -12.86% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -61.10% | -53.96% | -56.26% | -57.57% | -12.86% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -61.10% | -53.96% | -56.26% | -57.57% | -12.86% |
|
|
|||||